ABOUT US

10FoldMed™ is an early stage startup, located in Israel, with the vision to treat Obesity and Metabolic related diseases, by reversing the Insulin Resistance of the patient,  post a Non-Invasive Destruction of Visceral Fat Cells, by 10Fold™, patent pending technology.
The technology represents a breakthrough in the Focus Ultrasound field, enabling a controlled, precise, Self-Guided, Focused Ultrasound based device, combined with machine learning capabilities. The technology is in the development stage.

The company is self-funded, with a support by the Israeli Innovation Authority (IIA).
For more information please contact us at admin@10foldmed.com.